Our portfolio ranges from single-centre to multi-centre, national to international, phase II to phase IV drug trials, as well as other randomised control trials and well designed studies.
A Phase 2, multi-arm, multicentre, non-randomised, proof-of-mechanism (single and combination IMPs) trial using a Bayesian adaptive design. A multi-centre trial. 2 centres initially planned - this may be reduced or increased in order to recruit…
